S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CPRX Catalyst Pharmaceuticals Inc

22.32

0.00 (0.00%)

Pre Market

Last Updated: 20:28:17

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
Tuesday 4 March 2025 (13 hours ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 March 2025 (19 hours ago) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Saturday 1 March 2025 (3 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 February 2025 (6 days ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Thursday 27 February 2025 (6 days ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 27 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

More Catalyst Pharmaceuticals Inc News Articles

Commonwealth Bank Of Aus...

Verizon Communications

Sterling vs AUD

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions